Blocking the MyD88-dependent pathway protects the myocardium from ischemia/reperfusion injury in rat hearts
- 16 December 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 338 (2) , 1118-1125
- https://doi.org/10.1016/j.bbrc.2005.10.068
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- NF-κB activation is required for the development of cardiac hypertrophy in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Toll-like receptor 4 mediates ischemia/reperfusion injury of the heartThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient MiceCirculation, 2004
- Modulating Toll-like receptor mediated signaling by (1→3)-β-?-glucan rapidly induces cardioprotectionCardiovascular Research, 2004
- MyD88S, a splice variant of MyD88, differentially modulates NF‐κB‐ and AP‐1‐dependent gene expressionFEBS Letters, 2003
- Phosphatidylinositol 3‐kinase is involved in Toll‐like receptor 4‐mediated cytokine expression in mouse macrophagesEuropean Journal of Immunology, 2003
- NF-κB as an Integrator of Diverse Signaling Pathways: The Heart of Myocardial Signaling?Cardiovascular Toxicology, 2003
- Toll-like receptor–mediated NF-κB activation: a phylogenetically conserved paradigm in innate immunityJournal of Clinical Investigation, 2001
- Dominant Negative MyD88 Proteins Inhibit Interleukin-1β/Interferon-γ-mediated Induction of Nuclear Factor κB-dependent Nitrite Production and Apoptosis in β CellsJournal of Biological Chemistry, 2000
- In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarctionNature Medicine, 1997